Ultrastructural and molecular heterogeneity in non-small cell lung carcinomas:: Study of 110 cases and review of the literature

被引:12
作者
Bombi, JA
Martínez, A
Ramírez, J
Grau, JJ
Nadal, A
Fernández, PL
Palacín, A
Cardesa, A
机构
[1] Univ Barcelona, Hosp Clin Barcelona, Dept Pathol, Fac Med,IDIBAPS, E-08036 Barcelona, Spain
[2] Univ Barcelona, Hosp Clin Barcelona, Dept Med Oncol, Fac Med,IDIBAPS, E-08036 Barcelona, Spain
关键词
cyclin D1; heterogeneity; non-small cell lung cancer; pathology; ultrastructure;
D O I
10.1080/01913120290076892
中图分类号
TH742 [显微镜];
学科分类号
摘要
The authors reviewed a series of 110 surgical specimens of primary non-small cell lung carcinomas from the Department of Pathology at the Hospital Clinic, University of Barcelona Medical School, between 1987 and 1997. The sample included 25 squamous cell carcinomas, 60 adenocarcinomas, 14 large cell carcinomas, and 11 neuroendocrine tumors. Electron microscopic subcellular characteristics of the lung cancer cells were studied to define the squamous, adenoid, or neuroendocrine differentiation in each tumor. An immunohistochemical study for Cyclin D1 was performed in 96 cases. In 71 cases (65%) the author found a single ultrastructural differentiation, and in 30 cases (27%) ultrastructural differentiation was double: 25 adenosquamous and 5 adeno-neuroendocrine. In 3 cases a triple adeno-squamous-neuroendocrine differentiation was found. There were no cases of squamous-neuroendocrine differentiation. In 6 cases no differentiation of any kind could be found. Cyclin D1 overexpression was found in 58% of all tumors. The positive expression rates in squamous cell carcinoma and adenocarcinoma were 72% and 62%, respectively. In purely adenoid-differentiated tumors there was a strong association between high Cyclin D1 overexpression and differentiation (p = .006). In bronchioloalveolar carcinoma the positivity rate was 70%; all were heavy expressers, compared with 25% of heavy expressers in adenocarcinomas as a whole (p < .005). In purely squamous tumors differentiated ultrastructurally no relationship was found between high Cyclin D1 expression and degree of differentiation (p = .08). Lung cancers are morphologically and molecularly heterogeneous, and certain molecular alterations are related to specific subcellular characteristics.
引用
收藏
页码:211 / 218
页数:8
相关论文
共 51 条
[1]  
Bennett WP, 1999, J PATHOL, V187, P8, DOI 10.1002/(SICI)1096-9896(199901)187:1<8::AID-PATH232>3.0.CO
[2]  
2-Y
[3]   Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer [J].
Betticher, DC ;
Heighway, J ;
Hasleton, PS ;
Altermatt, HJ ;
Ryder, WDJ ;
Cerny, T ;
Thatcher, N .
BRITISH JOURNAL OF CANCER, 1996, 73 (03) :294-300
[4]  
BOLEN JW, 1982, PATHOL ANNU, V17, P77
[5]  
Brambilla E, 2000, SEMIN DIAGN PATHOL, V17, P138
[6]   Prognostic role of cyclin D1 in lung cancer - Relationship to proliferating cell nuclear antigen [J].
Caputi, M ;
Groeger, AM ;
Esposito, V ;
Dean, C ;
De Luca, A ;
Pacilio, C ;
Muller, MR ;
Giordano, GG ;
Baldi, F ;
Wolner, E ;
Giordano, A .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 20 (04) :746-750
[7]   Immunoelectron microscopy for chromogranin a in small cell neuroendocrine carcinoma of lung [J].
Dardick, I ;
Christensen, H ;
Stratis, M .
ULTRASTRUCTURAL PATHOLOGY, 1996, 20 (04) :361-368
[8]   Cell cycle regulators and their abnormalities in breast cancer [J].
Fernández, PL ;
Jares, P ;
Rey, MJ ;
Campo, E ;
Cardesa, A .
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1998, 51 (06) :305-309
[9]   The epidemiology of lung cancer [J].
Franceschi, S ;
Bidoli, E .
ANNALS OF ONCOLOGY, 1999, 10 :3-6
[10]   NEUROENDOCRINE CARCINOMA OF LUNG, INTERMEDIATE SIZE CELL TYPE [J].
GOULD, VE ;
WARREN, WH ;
MEMOLI, VA .
ULTRASTRUCTURAL PATHOLOGY, 1983, 5 (04) :291-297